Female Athlete Triad and RED-S

ვარჯიში · §424

Your hands stay cold in warm rooms. Your last real period was sometime in college, and you took it as a sign of finally training seriously. The third stress fracture this year was the same bone as the second. None of it is what it looks like: your body has read your training load and your meals as a famine, and it is rationing reproduction, immunity, and bone formation to keep the basics on. The fix is older than most of medicine — enough food, sustained — and most of what you didn't know you were losing comes back.

Know · As-needed Evidence Moderate თავი ვარჯიში

This is one of the more cleanly evidenced conditions in sports medicine: three independent expert panels arrive at the same cascade and the same fix. Recognising and correcting it lifts the whole picture — warmth, energy, focus, mood, the missing period, the stress-fracture rate — within weeks to months. The catch is that the cure is eating more and training less, which sounds easier than it is. For people whose identity is built on leanness and discipline, the head is the hard part. And the bone you lose in your twenties is not fully bone you get back.

The substance under all of this has a name nobody loves: low energy availability, or LEA. The arithmetic is simple. Take everything you eat in a day. Subtract everything you burn doing exercise on top of just-being-alive. What is left has to fund every other thing your body does — repair tissue, build bone, ovulate, fight off a cold, keep your hands warm, think clearly. Under about 30 calories per kilo of lean tissue per day — for a typical female runner that is somewhere south of 1,500 to 1,800 calories left after training — the math stops working. The body reads the gap as famine and switches off the parts it judges optional.

The first thing it switches off is reproduction. A small clock in the brain stops pulsing. The hormone that tells the ovary to ovulate drops, oestradiol drops, the period thins out and then stops altogether. With oestradiol gone, the brake comes off bone breakdown — and at the same time, two of the hormones that build bone (IGF-1 and insulin) shut down too. Bone falls on both ends of the equation. Thyroid output drops, which is why a long-running underfuelled person is cold all the time and has a strangely low resting metabolism for someone training so hard. Cortisol rises, sleep gets thinner, mood flattens, immunity dips, gut motility slows. None of these is a side effect of training. They are all the same signal: not enough food coming in to keep the lights on.

How sure we are this matters

Three independent panels of experts have looked at this and arrived at very similar pictures: the American College of Sports Medicine in 2007 ACSM 2007, the Female Athlete Triad Coalition in 2014 De Souza et al. 2014, and the International Olympic Committee's RED-S consensus, updated through 2014 and 2023 Mountjoy et al. 2014 IOC 2023. They argue about how broadly to draw the box around the syndrome — RED-S extends it to men and to immune, metabolic, and performance effects, while the older "Triad" framing stays tighter on women's periods and bone — but the upstream story they tell is the same. Underfuel an active body and a specific cascade follows.

The effect sizes are large enough that you see them in any prospective study that thinks to look. In a season of elite distance runners, athletes flagged as at risk of LEA suffered roughly four and a half times more bone injuries — and a meaningfully longer pile of sick days — than their better-fed teammates Heikura et al. 2018. In a multi-site cohort of 239 exercising girls and women, the number of triad components an athlete carried predicted incident stress injury in a graded line: one risk factor put yearly injury rates around 15-21%; three risk factors pushed it to 30-50% over a single year Barrack et al. 2014. In junior elite female swimmers, those with suppressed cycles failed to improve their 400-metre time across twelve weeks of training; the eumenorrheic teammates doing the same workouts got faster by about eight percent Vanheest et al. 2014. The training was identical. The fuel was not.

Prevalence is what tells you it is not a niche concern. Across elite female endurance sports — distance running, cycling, triathlon, cross-country skiing — estimates of who is in LEA run from 22-58% depending on how you measure Logue et al. 2018. In aesthetic sports — gymnastics, dance, figure skating, diving — the numbers are similar or higher. And even outside elite ranks, in recreational female exercisers who are not chasing a podium, a meaningful share spend at least some weeks below the threshold.

Who this is actually about

The picture in your head is probably the elite distance runner. She is the central case — endurance sport, lean aesthetic, high training volume, female. But the audience is wider than that, in three directions.

Recreational exercisers count. The 28-year-old who runs fifty kilometres a week for fun, eats "clean," lifts a few times, and has not had a real period in three years is the modal case in the general population. She is not at any Olympic combine. Her doctor probably told her the missing period was "your body adjusting to training" and offered her the pill. She is exactly who this is about. The CrossFit obsessive who cut her intake again last month to drop the last few pounds belongs in the same bucket.

Adolescents are the highest-stakes group. Peak bone mass — the lifetime ceiling for how strong your skeleton ever gets — is laid down between roughly age 11 and 20. Years lost in there do not fully come back later Drinkwater et al. 1990. A teenage gymnast or distance runner with two stress fractures and no period for a year is borrowing from a bone account she will not be able to repay in her forties. The screening tools built by the Female Athlete Triad Coalition exist for this group specifically.

Men get a version of this too. The Triad's middle pillar — menstrual function — is female-only by definition, so the syndrome was named for women. But the upstream driver and most of the downstream effects apply to male endurance and aesthetic athletes too. In men, the biomarker that drops is testosterone rather than oestradiol; the bone-loss and stress-fracture risk are real; the libido drop, the fatigue, the performance plateau look much like the female picture Tenforde et al. 2016. The evidence base in men runs about fifteen years behind the female literature, but the syndrome is real enough that the IOC consensus covers it. If you are a male endurance athlete with persistent fatigue, repeated stress fractures, and a libido that has quietly gone missing, this is on your list too.

What keeps happening if you let this run

The short timescale is the one the reader notices first. The morning that starts already tired. The fourth cold of the winter, the cut on the shin that takes three weeks to close. The 4pm wall that needs a third coffee. Workouts that used to feel like running now feel like dragging — the watts are not there, the splits are slower, the bounce is gone. Recovery between sessions stretches out; the workout you used to repeat in 48 hours now needs 96. The desire that used to be there — to train, to be with your partner, to take on the project at work — is quietly somewhere else.

The middle timescale is bone and breakage. The stress reaction in the tibia that became a stress fracture that became four months in a boot, then six months back into training, then another stress reaction in the femoral neck. People around you start to comment that you seem to break a lot. The dermatologist asks if you have been sleeping. Your dentist mentions your gums. Your hair is thinner than it was at twenty-three.

The long timescale is the one nobody wants to look at, and it is the most important. The lumbar spine and femoral-neck bone density you build in your twenties is the bone you have at sixty-five. Drinkwater's classic work on young athletes showed that years of missed periods tracked linearly with bone density deficits — and crucially, much of that deficit did not come back even after periods returned Drinkwater et al. 1990. A wrist that breaks on a slip in your fifties; the vertebra that compresses in your sixties; the femoral neck that fails after a small fall in your seventies, the one that historically takes about a year off the back end of life. None of these are written into the headline of the syndrome. They are written into its trajectory.

The other long-arc costs are quieter. Lipid panels that drift the wrong way IOC 2023. Fertility windows that do not look quite like the ones their owners expected. A psychiatric overhang — the flatness and the dread — that some women carry years past the point where they have stopped training. The triad does not kill anyone in the news. It just trims years off the back of life in a quiet, well-distributed way.

What most people get wrong about this

"Losing your period means you're a real athlete." This is the oldest and most damaging idea in the room. A period stops because the brain has read a famine and switched reproduction off — it is a sign of dysfunction, not fitness. Controlled studies show that athletes with normal cycles outperform their suppressed teammates on the same training Vanheest et al. 2014. The strong women you watched cross the line in the marathon were almost certainly menstruating; the ones who broke and disappeared were not.

"The pill protects my bones." A withdrawal bleed on an oral contraceptive looks like a period and is not one. The pill does not turn the brain's reproductive clock back on, does not restore IGF-1 or thyroid output, and has weak and contradictory evidence for protecting bone in this specific syndrome. Both major clinical consensus statements explicitly exclude the pill as a first-line treatment for this De Souza et al. 2014 IOC 2023. Starting it on top of an unfixed energy gap mainly removes the most useful biomarker — the spontaneous return of your real period — and lets the underlying syndrome run on, invisible.

"My bone scan is normal, so I'm fine." Bone density on a DXA scan lags energy availability by months to years. The hormones that drive bone formation drop within days of falling below the threshold Ihle & Loucks 2004. A current scan that comes back normal in a long-running underfuelled athlete is not a clean bill; it is the bone account you have left to spend.

"It's just an eating disorder." It can be. It often is not. A well-meaning athlete who has never had a disordered thought about food can produce the same physiology by eating what feels normal and training above what that intake supports. The clinical framework explicitly covers low energy availability "with or without disordered eating" ACSM 2007. The fix is the same; the path in is not.

"I look healthy, so this doesn't apply." Body weight and body composition are poor proxies for energy availability. Plenty of women who carry this syndrome are at a normal or even higher BMI; their intake is just not keeping up with their output Logue et al. 2018. The mirror is not the diagnostic.

"It only happens to women." The historical name was female-specific. The underlying problem — too little fuel for too much training — is not. Male endurance and aesthetic athletes get the parallel version, with testosterone in the role oestradiol plays in women, and the same bone, mood, and performance consequences Tenforde et al. 2016.

What to do

The lever is the same lever Loucks's controlled work pinned down: get energy availability back above the threshold and hold it there. In practice that means more food, sometimes less training, and patience measured in months. The cleanest refeeding trial in oligomenorrheic athletes pushed intake up by roughly 300 to 500 calories a day above baseline, kept training constant, and restored periods in most participants over about six months Cialdella-Kam et al. 2014. That is the rough shape of the work.

If you have one, talk to a sports-medicine physician or a sports dietitian — not your regular GP, who may default to writing a prescription for the pill. The condition is specialty-recognised; specialists who see it routinely will not gaslight you about your periods.
Step one is intake. Aim to add roughly 300 to 500 calories a day above your current baseline, weighted toward carbohydrate and protein. Hold this for at least six months before judging it.
If intake cannot rise that far — appetite, schedule, food access — reduce training-energy expenditure instead. A scheduled rest day, a shorter long run, an extra week-off in the year. Both ends of the equation are valid levers.
Track your real period (not a pill bleed). The return of a spontaneous cycle is the most useful single signal that the underlying physiology has switched back on.
Get a baseline DXA scan. Repeat it at 12 to 24 months to track the trajectory.
If disordered eating is part of the picture, mental-health support is part of the protocol. Refeeding without addressing the driver tends to fail.

Two things this is not. It is not a one-week refuel. The endocrine system is slow; weeks of compliance do not undo years of suppression, and stopping early because "it didn't work" is one of the most common reasons recovery stalls. And it is not, in any clinical guideline written this decade, the contraceptive pill De Souza et al. 2014 IOC 2023.

Where this commonly goes wrong

The diagnosis arrives late. The average gap between losing a period and a doctor naming this is years. Most cases are diagnosed only after a stress fracture forces an imaging visit. Primary-care clinicians who do not see athletes routinely often default to "your training is the problem" and prescribe the pill — which both masks the syndrome and erases the cleanest biomarker for tracking it De Souza et al. 2014.

The refeeding is half-hearted. Eating 100 more calories a day for two months does not move the needle. Sustained increases of 300 to 500 calories per day for six-plus months are roughly the threshold of intervention that actually restores menses in the published trials Cialdella-Kam et al. 2014. Eating-disorder voices that whisper "this is enough" are not reliable evaluators of what is enough.

The training keeps eating the food. Pushing intake by a few hundred calories while ramping volume by the equivalent amount leaves energy availability unchanged. If you cannot eat enough to outpace the work, you have to reduce the work — temporarily, on a clear timeline.

The athlete drops out before bone catches up. Menstrual function returns within months; bone density takes one to two years to partially recover and may never reach where it would have been. Athletes who restore their period and immediately revert to the prior intake-training balance often re-enter the syndrome silently and lose the bone-recovery window.

The disordered-eating piece goes untreated. When restrictive thinking sits underneath the syndrome, refeeding alone has a high relapse rate. The clinical recommendation in this case is medical and mental-health management together, not sequentially.

The athlete is told their period will come back "when they're done racing." Sometimes it does. Sometimes it does not, and the bone deficit that accumulated through those years is permanent. "Get through the season and worry about it after" is a coaching instinct that has cost the field many athletes.

What comes back when you fix it

Week one and two. The first thing you notice is not virtue. It is warmth. Your hands stop being cold in rooms where nobody else is cold. Thyroid output starts to climb back up, and the strange low metabolism normalises along with it Hilton & Loucks 2000. Sleep gets thicker — the 3am wake fades because cortisol stops spiking on an empty stomach. You are less irritable at the people around you, less brittle in meetings. People who know you start to mention you seem brighter, though nobody knows why.

Weeks three to twelve. The fog lifts. You had not noticed the fog — you had thought you were just like that, a flat person, a foggy person, a person who did not enjoy their workouts the way they used to. The session that used to feel like dragging starts to feel like running again. Recovery between sessions tightens; the workout you used to repeat once a week becomes twice a week. You stop catching every cold the office brings in. Libido turns up where it has been quietly missing.

Three to twelve months. The period comes back, for many readers for the first time in years. It is not just a fertility marker — it is the body's note that it has decided the environment is safe again, that the famine signal is off. Refeeding trials get most participants back to spontaneous cycles inside this window Cialdella-Kam et al. 2014. The performance plateau breaks. The swimmer who could not improve her 400-metre time for a year improves by something like eight percent over the next twelve weeks of the same training — the gap that opens up between her and her suppressed teammates in the published work Vanheest et al. 2014.

Year one onward. Bone density stops falling. In a teenager caught early, peak bone mass partially recovers. In a young adult, the trajectory flips from net loss to slow hold or modest rebuild. Stress reactions on the next MRI come back fewer. The lipid panel that had been drifting the wrong way drifts back. The training finally builds something.

Years out. The retirement-from-sport scenario looks different. You are not the retired runner with osteopenia at thirty-five, the one who breaks a wrist on a normal slip. Your fertility window, when you wanted it, was a normal fertility window. The flatness and the dread before workouts are a memory rather than a personality. The athlete you thought you were buying with restriction shows up — once you stop paying for her that way.

What the work actually costs

The intervention itself is mostly behavioural and mostly free — you are already eating; you eat a bit more, and you sometimes train a bit less. The small line items: a sports-medicine consultation if you can get one, a sports dietitian for a few sessions if affordable, and a baseline DXA scan at $100 to $300 to track bone density. The screening tools are free: the LEAF-Q is a 39-item self-administered questionnaire validated for female athletes Melin et al. 2014, and the IOC's RED-S Clinical Assessment Tool is publicly available for clinicians to walk through risk-stratification.

The timelines worth planning around: warmth, sleep, mood, and energy start moving within weeks. The period typically returns somewhere in the three-to-twelve-month window. Bone density takes one to two years to partially recover. Full athletic performance reconstitution runs six to eighteen months in most cases. None of these are quick. Setting expectations that match the biology is part of not giving up at month four.

Two practical traps. The first is the family doctor who has not seen this before and offers the pill; if that happens, advocate for a sports-medicine referral rather than accepting the prescription. The second is well-meaning fitness culture that frames "eating more" as the wrong direction; the right people to listen to here are sports dietitians who routinely fuel female athletes, not generic wellness influencers.

Adjacent rabbit holes

A few topics this entry deliberately stops at the edge of, that a reader following the thread out may want to look at next.

Disordered eating and clinical eating disorders. When restrictive thinking sits underneath the syndrome, that is its own substantial topic — anorexia and bulimia have specific treatment literatures that go well beyond refeeding.
Functional hypothalamic amenorrhea outside athletics. The same brain-clock-switches-off mechanism happens with stress, sleep deprivation, or weight loss unrelated to exercise; the cascade and most of the fix overlap.
Bone density screening and osteoporosis prevention. The DXA scan, the lifestyle and pharmacological side of bone health, and when premenopausal women should be screened.
Carbohydrate availability around training. A live debate in sports nutrition about whether within-day carbohydrate timing — not just total daily intake — independently affects bone, immunity, and adaptation.
Hormonal contraception in athletes. The trade-offs of the pill, the IUD, and other methods in athletic populations, including the bone-density and performance effects of each.
Stress fracture management and return-to-running. The orthopaedic and rehabilitation side of bone stress injuries once they have happened.
Male athlete LEA and testosterone suppression. The male parallel deserves its own detailed entry as that evidence base matures.

Substance and claimed effects

The substance is low energy availability (LEA) in physically active people — a state in which dietary energy intake minus exercise energy expenditure, expressed per kilogram of fat-free mass, falls below the level required to support normal physiological function. The historical clinical framing in women is the Female Athlete Triad: the interrelated triad of LEA (with or without disordered eating), menstrual dysfunction (functional hypothalamic amenorrhea or oligomenorrhea), and reduced bone mineral density / increased stress-fracture risk ACSM 2007 De Souza et al. 2014. Relative Energy Deficiency in Sport (RED-S, REDs) is the broader IOC-consensus model that retains LEA as the upstream driver but extends downstream sequelae to additional systems — endocrine (thyroid, IGF-1, leptin, cortisol), metabolic rate, immune function, cardiovascular markers, gastrointestinal function, haematology, growth/development, psychological state, and athletic performance — and applies the framework to male athletes as well Mountjoy et al. 2014 IOC 2023. This entry treats LEA as the substance and covers the full spectrum of consequences across menstrual function, bone, metabolism, immunity, mood, performance, and the male parallel.

Evidence by addressing question

Mechanism

Science. The canonical experimental work is Loucks's controlled-feeding short-trials in eumenorrheic women, in which energy availability was clamped at 45, 30, 20, and 10 kcal/kg FFM/day for five days while exercise expenditure was held constant. Luteinizing hormone (LH) pulse frequency and amplitude declined sharply below ~30 kcal/kg FFM/day, with no disruption at 45 Loucks & Thuma 2003. The same paradigm showed triiodothyronine (T₃) fell at <30 kcal/kg FFM/day independent of exercise stress Hilton & Loucks 2000, and bone-turnover markers decoupled with reduced bone formation (P1NP, osteocalcin) and increased resorption (NTX) under the same threshold Ihle & Loucks 2004. The mechanistic chain runs LEA → suppressed hypothalamic GnRH pulse generator → reduced LH/FSH → low oestradiol and progesterone → impaired osteoblast activity and oestrogen-deficient bone loss. In parallel, LEA suppresses the somatotropic axis (low IGF-1 with GH resistance), the thyroid axis (low T₃), and leptin, while raising cortisol and ghrelin — a survival-mode endocrine reconfiguration that defunds reproduction, growth, and immunity in favour of basal survival Mountjoy et al. 2014 Areta et al. 2021.

Mechanism extension. Bone is doubly hit: oestradiol deficiency removes the brake on osteoclast activity, while low IGF-1 and low insulin reduce osteoblast-driven formation. The result is uncoupled remodelling — net loss particularly at the trabecular sites (lumbar spine, femoral neck) with relative preservation of cortical bone except at high-impact long bones where stress reactions concentrate ACSM 2007. Skeletal muscle protein synthesis falls during short-term energy deficit and is partially rescued by resistance exercise plus protein ingestion Areta et al. 2014, which explains why endurance athletes lose lean mass and power in LEA states. Resting metabolic rate adapts downward beyond what fat-free mass loss alone predicts, producing the clinically observed "metabolic suppression" of chronically under-fuelled athletes IOC 2023.

Evidence — does LEA actually drive the cascade?

Science. Beyond Loucks's threshold experiments, prospective observational work in elite distance runners shows that athletes screened as at-risk on LEA surrogates suffered 4.5-fold higher bone injury rates and significantly more illness days over a season Heikura et al. 2018. In a multi-site prospective cohort of 239 exercising girls and women, the cumulative count of triad risk factors (LEA, menstrual dysfunction, low BMD) predicted incident bone stress injury in a graded, dose-response fashion: athletes with 1 risk factor had ~15-21% incidence over 1 year, climbing to ~30-50% with 3 risk factors Barrack et al. 2014. The cross-sectional landmark in female runners — Cobb et al. — found amenorrheic runners had bone mineral density Z-scores ~1 SD below eumenorrheic peers, and disordered eating independently predicted reduced BMD Cobb et al. 2003. Drinkwater's earlier work documented that years of disrupted menses tracked linearly with lumbar spine BMD deficits — and crucially, much of the deficit failed to recover after menses returned, establishing the irreversibility concern for adolescent athletes Drinkwater et al. 1990. A controlled trial of dietary refeeding in oligomenorrheic exercising women restored eumenorrhea in 5 of 8 participants over 6 months with no reduction in exercise — proof-of-concept that the cascade is genuinely energy-mediated and reversible at the menstrual level Cialdella-Kam et al. 2014. Performance evidence: junior elite female swimmers with ovarian suppression (a marker of LEA) failed to improve 400-m swim time over a 12-week training block, while eumenorrheic teammates training the same workload improved by ~8% Vanheest et al. 2014.

Practice / clinical consensus. The 2007 ACSM position stand reframed the triad as a spectrum from optimal energy availability + eumenorrhea + healthy BMD to clinical LEA/eating disorder + amenorrhea + osteoporosis, and made LEA the primary driver ACSM 2007. The 2014 Female Athlete Triad Coalition consensus formalised a cumulative risk assessment scoring tool and return-to-play criteria De Souza et al. 2014. The IOC's RED-S consensus (2014, 2018, 2023) extended the model to multiple systems and to males, introduced the IOC RED-S CAT and Clinical Assessment Tool, and clarified that current screening instruments identify risk, not LEA directly, since measuring true energy availability requires gold-standard methods (doubly-labelled water, indirect calorimetry, validated food/training records) that are infeasible outside research IOC 2023. The 2023 update emphasises a syndrome model with primary indicators (low EA, suppressed reproductive hormones, low BMD) and secondary indicators (metabolic rate, growth markers, immunological markers, GI symptoms) and acknowledges males require independent validation.

Community / lay evidence. Athletic communities — particularly endurance running, cycling, lightweight rowing, aesthetic sports (gymnastics, figure skating, dance), and weight-class combat sports — have long-standing folk knowledge that "lost periods come with serious training," historically misinterpreted as a sign of fitness rather than dysfunction. The "leanness pays" cultural assumption produces survivorship bias in elite cohorts (the athletes who race well at very low body fat are visible; those who break and drop out are not) and shapes coach/athlete decisions despite contrary evidence. Online communities (r/AdvancedRunning, dietitian-athlete TikTok, ultrarunning forums) have shifted markedly toward RED-S awareness since ~2018, partly driven by high-profile cases (Mary Cain, Allie Ostrander, Bobby Clay, Megan Roche) and the Atalanta NYC podcasts. The community signal is now substantially aligned with the consensus literature, though clinical recognition still lags markedly behind community awareness.

Population prevalence. Estimates vary by population and assessment method. In elite female endurance athletes, LEA prevalence ranges from ~22-58% depending on screening tool, and menstrual dysfunction prevalence ranges ~30-60% in lean and endurance sports compared to ~5-12% in the general population Logue et al. 2018 Mountjoy et al. 2014. Among collegiate female athletes screened with surrogate triad criteria, ~16% met two or more triad components and ~1% met all three Logue et al. 2018. In recreational exercisers (not elite), LEA is also common — one study found ~45% of female recreational exercisers had EA <30 kcal/kg FFM/day on at least one assessment day.

Protocol — how is LEA addressed?

Science. The therapeutic target is restoring energy availability above ~45 kcal/kg FFM/day, the threshold associated with normal endocrine function in Loucks's work Loucks & Thuma 2003. Refeeding studies in oligomenorrheic athletes have used increases of ~300-500 kcal/day above baseline intake without reducing training, sustained for 6+ months, and shown menstrual recovery in a majority of participants Cialdella-Kam et al. 2014. Longer-term magnitude-of-deficit work by Williams et al. demonstrates that the frequency (not severity) of menstrual disturbance correlates with the size of the energy deficit, and that resolution requires reversing the deficit, not exercise modification alone Williams et al. 2015. The Female Athlete Triad Coalition treatment statement recommends a stepped intervention: (1) increase energy intake by ~20-30% above current, prioritising carbohydrate to support training; (2) reduce exercise energy expenditure where intake cannot rise sufficiently; (3) target body weight increase of ~5-10% if BMI is low; (4) multidisciplinary team (physician, sports dietitian, mental health if eating disorder present, endocrinology for low BMD); (5) DXA at baseline and at intervals; (6) return-to-play graded by risk score De Souza et al. 2014. The Female Athlete Triad Coalition Cumulative Risk Assessment scores eight categories from 0-2 each (eating disorder, BMI/weight, menstrual function, BMD, stress-injury history) and gates return-to-play.

Practice. Specialist sports-medicine clinics typically use the IOC RED-S CAT or the Triad Coalition CRA, combined with the LEAF-Q questionnaire (39 items, validated in female endurance and aesthetic-sport athletes, identifies long-term LEA risk with sensitivity ~78% and specificity ~90%) Melin et al. 2014. DXA is the standard for BMD assessment; in adolescents, Z-scores are used rather than T-scores. Resting metabolic rate measurement (RMR_measured/RMR_predicted ratio <0.90) is used as a surrogate for metabolic suppression where indirect calorimetry is available IOC 2023. Hormonal contraceptives are explicitly not first-line treatment in clinical guidelines, because the induced withdrawal bleed masks the spontaneous-menses biomarker without correcting the underlying LEA or providing reliable bone protection De Souza et al. 2014 IOC 2023.

Audience — who is at risk

Science. Highest-risk populations: female athletes in endurance sports (distance running, cycling, triathlon, cross-country skiing), aesthetic sports (gymnastics, ballet, figure skating, diving), weight-class sports (lightweight rowing, jockeys, combat sports), and lean-focused recreational populations (CrossFit, fitness models). Within these populations, risk concentrates in adolescents and young adults during peak training years, and in those with disordered eating or dietary restrictions (vegan/vegetarian without compensatory planning, "clean eating" cultures). Male athletes in the same sport categories develop a parallel syndrome with the same upstream LEA driver: reduced testosterone, reduced libido, low BMD, reduced performance, and increased stress fracture risk Tenforde et al. 2016. Adolescent athletes are particularly vulnerable because peak bone mass is acquired in the 11-20 year window; deficits acquired then are difficult-to-impossible to recover Drinkwater et al. 1990. Pregnancy, postpartum, and the perimenopausal transition each introduce independent endocrine pressures that interact with training-induced LEA; pregnancy is an absolute contraindication for the LEA state itself.

Community. Recreational populations (non-elite, hobby-level training) are increasingly recognised as a substantial share of LEA cases. The phenotype is the "fit healthy" woman running 40+ km/week, eating "clean" with implicit caloric restriction, who has had no period for years and considers it normal. Coach culture historically dismissed missed periods as a positive sign in endurance women; the shift toward treating amenorrhea as a red flag is recent and incomplete.

Misconceptions

Science. Several widely-held beliefs are wrong:

"Missing periods means you're a serious athlete." Loss of menses signifies hypothalamic suppression from energy deficiency and is a marker of dysfunction, not fitness. Eumenorrheic athletes outperform their amenorrheic peers in controlled training studies Vanheest et al. 2014.
"The pill protects my bones." Oral contraceptives induce withdrawal bleeding that mimics a period but do not restore the underlying hypothalamic-pituitary-ovarian axis, do not normalise IGF-1 or other LEA-suppressed hormones, and have weak/contradictory evidence for bone protection in functional hypothalamic amenorrhea. Clinical guidelines explicitly exclude OCPs as a first-line intervention De Souza et al. 2014 IOC 2023.
"My DXA is normal, so I'm fine." BMD measured by DXA lags LEA by months to years; bone turnover markers decouple within days of EA falling below threshold Ihle & Loucks 2004. A normal current DXA in an LEA athlete predicts a worse future trajectory, not a clean bill.
"It only affects women." Male athletes develop the parallel syndrome with reduced testosterone, libido, BMD, and performance; risk concentrates in the same sport categories. The "Triad" name is historical and female-specific; the LEA driver is gender-shared Tenforde et al. 2016.
"It's just an eating disorder." LEA can occur without disordered eating — well-meaning under-fuelling, miscalculated energy needs, or simply training volume outpacing intake all produce the same physiology. The Triad/RED-S framework explicitly covers LEA "with or without disordered eating" ACSM 2007.
"I look healthy, so this doesn't apply." LEA can exist at normal or above-normal BMI; body composition is a poor proxy for energy availability. Recreational exercisers and even some weight-stable athletes have measurable EA below threshold Logue et al. 2018.

Failure modes — where intervention goes wrong

Science / Practice. The classic failure modes:

Under-recognition. Average time from menstrual dysfunction onset to diagnosis is years, often only triggered by a stress fracture. Primary-care clinicians frequently prescribe OCPs to restore a period without investigating LEA De Souza et al. 2014.
Athlete resistance. Increasing food intake and/or reducing training threatens athletic identity; adherence to refeeding protocols is the primary clinical challenge. Studies report partial-compliance refeeding fails to restore menses even over 12+ months Cialdella-Kam et al. 2014.
Bone density does not fully recover. Even with restored menses and normalised energy availability, lumbar BMD recovery is partial and slow over 2+ years; deficits acquired in adolescence may be permanent Drinkwater et al. 1990.
Hormonal contraception masks recovery. Starting OCPs erases the spontaneous-menses biomarker, leaving clinicians and athletes blind to whether LEA has actually resolved.
Co-existing eating disorders go unaddressed. Triad/RED-S protocols require mental health support when disordered eating is present; treating the energy deficit medically without addressing the psychological driver produces relapse.

Practicalities

Cost: the intervention is largely behavioural (eat more, train less, monitor cycle), with consultation costs (sports dietitian, sports medicine MD, possibly endocrinology). DXA scans run $100-300 typically. LEAF-Q is free and self-administered Melin et al. 2014. The IOC RED-S CAT is freely accessible. Cycle tracking via app is free. Time horizon: menstrual recovery typically takes 3-12 months from intervention onset; bone density recovery 12-24 months partial; full performance recovery 6-18 months. Insurance coverage for sports-medicine multidisciplinary teams is variable.

Stakes — what untreated LEA produces over time

Short-term (weeks-months): reduced training response, fatigue, declining performance, increased injury rates, immune suppression (frequent URIs, slow wound healing), constipation/GI dysmotility, depressed mood, reduced libido, irritability, poor concentration Mountjoy et al. 2014 Heikura et al. 2018.

Medium-term (months-years): stress fractures (tibia, metatarsals, femoral neck, sacrum), low BMD, reduced muscular power, blunted training adaptations, hair thinning, dry skin, cold intolerance, low resting metabolic rate, hypothyroidism-like fatigue, secondary amenorrhea with all its sequelae, infertility (anovulation), mood disorders, occasionally anaemia Barrack et al. 2014 Areta et al. 2021.

Long-term (years-decades): early osteoporosis and lifelong fracture risk (particularly hip and vertebral); permanent bone deficit from missed adolescent peak bone mass accrual; unfavourable lipid profile (elevated LDL); endothelial dysfunction; persisting menstrual dysfunction even after retirement from sport; subfertility; psychiatric morbidity in those with co-existing eating disorders Drinkwater et al. 1990 IOC 2023.

Payoff — what restoring energy availability produces

Short-term (weeks): energy lift, improved mood and concentration, warmer extremities (T₃ recovery), reduced URI frequency, improved recovery between training sessions, libido return.

Medium-term (months): menstrual cycle return (typically 3-12 months from intervention), reversal of metabolic suppression, gradual BMD stabilisation and partial recovery, return-to-baseline or above athletic performance, restored body weight at healthy composition, fewer stress reactions on follow-up imaging Cialdella-Kam et al. 2014 Vanheest et al. 2014.

Long-term (years): protected peak bone mass (in adolescents intervened early), restored fertility, normalised lipid profile, stable performance trajectory across career, reduced cumulative injury burden. The reversibility ceiling depends on age at intervention and duration of LEA before intervention.

History

The triad was first formally described by ACSM in 1992 (Yeager et al.) under the name "Female Athlete Triad" comprising disordered eating, amenorrhea, and osteoporosis. The 2007 ACSM position stand reframed it as a spectrum with low energy availability as the upstream driver — Loucks's work in the 1990s and early 2000s provided the experimental dose-response evidence that motivated the shift Loucks & Thuma 2003 ACSM 2007. The 2014 IOC consensus introduced "RED-S" to acknowledge the multisystem reach and extend the framework to male athletes Mountjoy et al. 2014. The 2018 and 2023 IOC updates refined the indicators, clinical tools, and male-athlete evidence base IOC 2023. The Triad Coalition has maintained the original female-specific framing alongside, with periodic disagreement about whether RED-S over-extends and whether male evidence is sufficient to support a unified syndrome model.

The credibility range

Optimist case. The Triad/RED-S framework is one of sports medicine's better-validated syndrome models. The upstream driver (LEA) has experimental dose-response evidence in humans Loucks & Thuma 2003 Ihle & Loucks 2004 Hilton & Loucks 2000. The downstream consequences are documented in prospective observational cohorts with effect sizes large enough to be clinically meaningful (4.5-fold bone-injury increase in at-risk athletes) Heikura et al. 2018 Barrack et al. 2014. Treatment proof-of-concept exists: refeeding restores menses in a majority of athletes within months Cialdella-Kam et al. 2014. Three independent consensus bodies (ACSM, Female Athlete Triad Coalition, IOC) converge on substantially similar clinical pictures. Community signal (athlete reports, coach experience) aligns with the literature. The optimist position is that this is a real, mechanistically coherent, partially-reversible syndrome with a clear primary lever (energy intake), and it is substantially under-recognised in clinical practice — most cases go undiagnosed for years.

Skeptic case. Several methodological concerns are real. Energy availability is exceedingly difficult to measure accurately outside the lab — self-reported intake under-reports by 20-40% in athletes, exercise-energy estimates are imprecise, and fat-free mass measurement varies by method Heikura et al. 2018. The 30 kcal/kg FFM/day threshold derives from short controlled trials in small samples and may not transfer cleanly to chronic free-living athletes — some athletes maintain function below it, others develop dysfunction above it. Some authors argue the RED-S model has out-extended the evidence base, particularly in males, where the parallel syndrome is plausible but the prospective evidence is thinner than in females Areta et al. 2021. The IOC consensus has been criticised for synthesising weak studies on equal footing with strong ones, and for an apparent IOC bias toward a unified syndrome label. Bone density recovery data is mixed — some studies show partial recovery, some show none, depending on age at onset, duration, and protocol. Hormonal contraception's role remains contested in practice despite consensus statements. Finally, the LEA framework risks pathologising normal training-day energy fluctuations; within-day deficits do not equal chronic LEA, and the field has not fully separated acute from chronic exposure.

The author's call. The upstream LEA → menstrual dysfunction → bone loss cascade in women is well-established (high evidence) and clinically actionable. The broader RED-S extension to multi-system effects (immunity, metabolism, mood, performance) is plausible-to-likely and supported by consistent observational data, though weaker than the core cascade. The male syndrome is real but the evidence base is appreciably thinner. The clinical bottom line — under-fuelled active people develop the syndrome, refuelling reverses much of it, oral contraceptives do not substitute for restoring energy availability, and bone deficits acquired in adolescence may be permanent — is robust enough to act on. The methodological controversy is primarily about measurement and threshold precision, not about whether the syndrome exists. evidence: 4 is right for the core female cascade; controversy: 3 reflects the active debate about RED-S extension and male evidence.

Stakeholder and incentive map

Pro / pushing the framework. Sports medicine specialists (USOC sports medicine team, IOC medical commission, Female Athlete Triad Coalition), sports dietitians, endocrinologists treating athlete populations, athlete-advocates (post-retirement athletes who experienced the syndrome and now speak publicly). Their incentive is patient outcomes plus academic visibility within a defined subspecialty.
Counter / pushback. Some elite coaches and federations whose competitive results historically came from leanness-selected populations have an implicit incentive against rapid culture change. Aesthetic-sport governing bodies (gymnastics, ballet, figure skating) face commercial pressure from a aesthetic that selects for low body weight. The pharmaceutical industry has no strong incentive — OCPs are off-label/unhelpful here, no specific drug treats LEA; the syndrome is largely behaviourally managed.
Mixed. Endurance-sport coaches: increasingly aligned with the consensus, but generational variation is wide. Recreational fitness industry: increasingly RED-S-aware, but "clean eating" and lean-aesthetic culture continues to drive cases.

Population variability

Sex. Female athletes are the historically defined population. The clinical triad (menstrual dysfunction is a sex-specific marker) is female-only by definition. RED-S extends the LEA driver and downstream effects to males with a parallel but distinct biomarker set (testosterone, libido, BMD) Tenforde et al. 2016.
Age. Adolescents and young adults are highest risk because of peak bone mass accrual and the convergence with sport-specialisation years. Adolescent-onset disease has the worst long-term BMD prognosis Drinkwater et al. 1990. Masters athletes can develop LEA but the bone-mass-acquisition window is closed.
Sport type. Risk concentrates in endurance (distance running, cycling, triathlon, cross-country skiing), aesthetic (gymnastics, dance, figure skating, diving), weight-class (lightweight rowing, jockeys, weight-cut combat sports), and gravitational (climbing). Ball-sport athletes and power-sport athletes have lower but non-zero prevalence.
Disordered-eating overlap. Roughly 20-40% of female athletes with the triad have a co-existing eating disorder; the remainder have LEA without diagnosable disordered eating. Treatment intensity and prognosis differ markedly across this divide.
Recreational vs elite. Both populations are affected; elite athletes are more screened, recreational exercisers more often miss the diagnosis entirely.
Hormonal contraception users. Women on OCPs cannot use spontaneous menses as a biomarker, and the literature applies poorly — most studies exclude OCP users.
Pregnancy / postpartum. Pregnancy is an absolute reason to ensure adequate energy availability; LEA in pregnancy threatens fetal growth. Postpartum return-to-sport with breastfeeding requires increased intake; many returning athletes inadvertently re-enter LEA.

Knowledge gaps

True energy-availability measurement. No feasible field method matches gold-standard accuracy. Surrogates (LEAF-Q, RMR ratio, biomarker panels) identify risk imperfectly. Methodological work on a usable EA measurement tool is the single biggest unmet need Heikura et al. 2018.
Chronic vs acute LEA. Whether brief within-day or within-week energy deficits produce the same physiology as sustained months-long LEA is unclear; some authors argue acute deficits are normal training and not pathological.
Threshold variability. The 30 kcal/kg FFM/day LH-disruption threshold comes from small short-trial cohorts. Individual variation, the role of carbohydrate availability independent of total energy, and threshold drift with training history remain open.
Male syndrome. Prospective evidence in male athletes lags female evidence by ~15 years. Specific male thresholds, biomarker panels, and return-to-play criteria need independent validation Tenforde et al. 2016.
Bone density recovery limits. The ceiling of recoverable BMD after LEA correction — particularly in those with adolescent-onset disease — is still poorly characterised. Pharmacological adjuncts (bisphosphonates, teriparatide) in young athletes remain investigational.
Performance reversal. Performance recovery trajectories after EA restoration vary widely and are not well-quantified at the individual level; coaches and athletes lack timeline expectations they can plan around.
Long-term reproductive outcomes. Fertility outcomes years after triad recovery are studied in small cohorts; whether retired athletes with prior triad have elevated subfertility or earlier menopause is unsettled.

Scope vs brief. The brief named menstrual cycles, bone density and stress-fracture risk, metabolism, immunity, mood, and athletic performance — all six are covered end-to-end in the body. The male RED-S parallel is covered as a parallel-syndrome paragraph in the audience section and again in misconceptions; it is not given its own deep dive because the evidence base remains roughly fifteen years behind the female literature and a dedicated male-LEA entry will land better as that base matures.

Audience scoping decision. The entry-level audience.gender is left unset rather than set to female. The Triad as a clinical syndrome is female by definition (menstrual function is its middle pillar), but RED-S extends the upstream LEA driver and most downstream effects to both sexes. Scoping female would under-serve male endurance athletes who fit the same picture. The applicability score (3) reflects an active-population-plus-awareness-audience read rather than a strict women's-health one.

Overall score / dream tier. Computed at ~38, just under the 40 obligatory threshold. Dream narrative written by choice because the relief lever is genuinely strong here — recognising the syndrome and correcting LEA does deliver the warmth/energy/period/performance cascade the narrative claims, with named hinges for each link. The dek and tagline therefore lean into the relief register without crossing into promise grammar.

Rating difficulties.

controversy: 3. The core female-triad cascade is consensus; the RED-S extensions (male syndrome, immune/metabolic/performance multisystem framing) are still contested in the literature. Picked 3 to reflect "active debate among reasonable experts" on the extension half, not on the core.
evidence: 4 (not 5). Loucks's dose-response work is strong, and three independent consensus bodies converge, but the RED-S clinical-tool validation literature is still maturing and energy-availability measurement remains imprecise outside the lab.
health_short_term: 4 vs 5. The QoL lift on correction is real and broad, but it is a return-to-baseline rather than a new transformative state — sat at 4.
longevity: 3. Bone deficits and lipid drift are real long-term consequences, but the mortality signal is mediated and diffuse — not a 4. Adolescent peak bone mass loss is the strongest long-term hook.
pull: 1. Recognition can be threatening; the corrective action runs against years of restriction. Low pull is part of why this entry's writing has to do a lot of work.

Action vs cadence. Picked know / as-needed because the reader's primary task is recognition; the response that follows (eat more, train less, see a sports-medicine physician) varies by severity and is structurally a multi-step protocol rather than a single avoid/do/test action. respond was the runner-up but undersells the awareness piece.

Hard decisions during the write.

Kept the 30 kcal/kg FFM/day threshold prominent despite the methodological caveat that the threshold derives from short controlled trials and may not transfer cleanly to chronic free-living athletes. The number is the only concrete handle a reader has, and the consensus statements still anchor on it.
Explicit OCP-doesn't-fix-this messaging in both misconceptions and protocol. This is the most clinically important misunderstanding in the field and worth the repetition.
The "athlete you thought you were buying with restriction" line in payoff borrows the narrative's aspirational tail; kept it because it earns the dream-narrative crank without overpromising.

Separate-entry candidates flagged in out-of-scope: disordered eating / clinical eating disorders, functional hypothalamic amenorrhea outside athletics, bone density screening and osteoporosis prevention, carbohydrate availability around training, hormonal contraception trade-offs in athletes, stress fracture management and return-to-running, male athlete LEA / testosterone suppression as its own entry once the evidence base matures.

Future link candidates (entries that probably should exist and this one should cross-link to): a DXA / bone-density entry, a functional hypothalamic amenorrhea entry, a sports-nutrition fueling-for-training entry, a hormonal contraception entry, a disordered-eating / eating-disorder-recognition entry, and eventually a dedicated male-RED-S entry.